Overview

Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

Status:
Completed
Trial end date:
2012-12-05
Target enrollment:
Participant gender:
Summary
This study will collect information on cycle control, acceptability and tolerability of the vaginal contraceptive ring (NuvaRing) as used in normal daily practice by Indian women.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Contraceptive Agents
Desogestrel
Ethinyl Estradiol
Etonogestrel
NuvaRing